{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:19:08Z","timestamp":1761920348801,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201308420488"],"award-info":[{"award-number":["201308420488"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12026-017-8955-6","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T10:44:28Z","timestamp":1507632268000},"page":"1130-1138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15"],"prefix":"10.1007","volume":"65","author":[{"given":"Yu","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Mouginot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loic","family":"Reppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongsheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-francois","family":"Stoltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00e8le","family":"Bensoussan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Decot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"8955_CR1","doi-asserted-by":"crossref","unstructured":"Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, et al. Prognostic factors on the graft-versus-host disease-free and relapse-free survival after adult allogeneic hematopoietic stem cell transplantation. Stem Cells Int. 2016;2016:5143071.","DOI":"10.1155\/2016\/5143071"},{"issue":"6","key":"8955_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbmt.2013.03.001","volume":"19","author":"M Bar","year":"2013","unstructured":"Bar M, et al. Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2013;19(6):949\u201357.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"12","key":"8955_CR3","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76(12):2462\u20135.","journal-title":"Blood"},{"issue":"6","key":"8955_CR4","first-page":"2715","volume":"194","author":"M Costa-Garcia","year":"2015","unstructured":"Costa-Garcia M, Vera A, Moraru M, Vilches C, L\u00f3pez-Botet M, Muntasell A, et al. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus. J Immunol Baltim Md 1950. 2015;194(6):2715\u201324.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"11","key":"8955_CR5","doi-asserted-by":"crossref","first-page":"13013","DOI":"10.18632\/oncotarget.7344","volume":"7","author":"SP Haen","year":"2016","unstructured":"Haen SP, et al. Prognostic relevance of HER2\/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab. Oncotarget. 2016;7(11):13013\u201330.","journal-title":"Oncotarget"},{"issue":"1","key":"8955_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bcmd.2007.06.029","volume":"40","author":"L Ruggeri","year":"2008","unstructured":"Ruggeri L, et al. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol Dis. 2008;40(1):84\u201390.","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"8955_CR7","first-page":"4421","volume":"146","author":"LL Lanier","year":"1991","unstructured":"Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM\/CD56). J. Immunol. Baltim. Md 1950. 1991;146(12):4421\u20136.","journal-title":"J. Immunol. Baltim. Md 1950"},{"issue":"7","key":"8955_CR8","first-page":"2923","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel T, et al. Human CD56bright NK cells: an update. J. Immunol. Baltim. Md 1950. 2016;196(7):2923\u201331.","journal-title":"J. Immunol. Baltim. Md 1950"},{"issue":"12","key":"8955_CR9","first-page":"6753","volume":"186","author":"V B\u00e9ziat","year":"2011","unstructured":"B\u00e9ziat V, et al. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J. Immunol. Baltim. Md 1950. 2011;186(12):6753\u201361.","journal-title":"J. Immunol. Baltim. Md 1950"},{"issue":"5","key":"8955_CR10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.coi.2008.07.004","volume":"20","author":"A Velardi","year":"2008","unstructured":"Velardi A. Role of KIRs and KIR ligands in hematopoietic transplantation. Curr Opin Immunol. 2008;20(5):581\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"8955_CR11","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","volume":"105","author":"KC Hsu","year":"2005","unstructured":"Hsu KC, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005;105(12):4878\u201384.","journal-title":"Blood"},{"issue":"31","key":"8955_CR12","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","volume":"25","author":"C Schmid","year":"2007","unstructured":"Schmid C, et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(31):4938\u201345.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"8955_CR13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bmt.1701413","volume":"22","author":"D Rondelli","year":"1998","unstructured":"Rondelli D, et al. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant. 1998;22(7):631\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"8955_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/bmt.2011.22","volume":"47","author":"Y-C Su","year":"2012","unstructured":"Su Y-C, et al. G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT. Bone Marrow Transplant. 2012;47(1):73\u201381.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"8955_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.exphem.2010.02.006","volume":"38","author":"V Decot","year":"2010","unstructured":"Decot V, et al. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression. Exp Hematol. 2010;38(5):351\u201362.","journal-title":"Exp Hematol"},{"issue":"2","key":"8955_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cyto.2012.06.021","volume":"60","author":"K Bogunia-Kubik","year":"2012","unstructured":"Bogunia-Kubik K, Gieryng A, Gebura K, Lange A, et al. Genetic variant of the G-CSF receptor gene is associated with lower mobilization potential and slower recovery of granulocytes after transplantation of autologous peripheral blood progenitor cells. Cytokine. 2012;60(2):463\u20137.","journal-title":"Cytokine"},{"issue":"10","key":"8955_CR17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0301-472X(02)00889-5","volume":"30","author":"M Saito","year":"2002","unstructured":"Saito M, et al. Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion. Exp Hematol. 2002;30(10):1115\u201323.","journal-title":"Exp Hematol"},{"issue":"1","key":"8955_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2009.03.509","volume":"132","author":"HC Toh","year":"2009","unstructured":"Toh HC, et al. G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo. Clin Immunol Orlando Fla. 2009;132(1):83\u201392.","journal-title":"Clin Immunol Orlando Fla"},{"issue":"8","key":"8955_CR19","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood.V90.8.3098","volume":"90","author":"JS Miller","year":"1997","unstructured":"Miller JS, Prosper F, McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood. 1997;90(8):3098\u2013105.","journal-title":"Blood"},{"issue":"1","key":"8955_CR20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/MO:21:1:81","volume":"21","author":"P Trzonkowski","year":"2004","unstructured":"Trzonkowski P, et al. Differences in kinetics of donor lymphoid cells in response to G-CSF administration may affect the incidence and severity of acute GvHD in respective HLA-identical sibling recipients. Med Oncol Northwood Lond Engl. 2004;21(1):81\u201394.","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"4","key":"8955_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0301-472X(01)00613-0","volume":"29","author":"H Tayebi","year":"2001","unstructured":"Tayebi H, et al. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol. 2001;29(4):458\u201370.","journal-title":"Exp Hematol"},{"issue":"1","key":"8955_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-2478(93)90165-X","volume":"39","author":"T Taga","year":"1993","unstructured":"Taga T, Kariya Y, Shimada M, Uchida A. Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: role of granulocyte colony-stimulating factor. Immunol Lett. 1993;39(1):65\u201370.","journal-title":"Immunol Lett"},{"issue":"15","key":"8955_CR23","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2009-06-227934","volume":"115","author":"T Baessler","year":"2010","unstructured":"Baessler T, et al. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells. Blood. 2010;115(15):3058\u201369.","journal-title":"Blood"},{"issue":"1","key":"8955_CR24","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1002\/ajh.23865","volume":"90","author":"M Lv","year":"2015","unstructured":"Lv M, et al. Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2015;90(1):E9\u2013E16.","journal-title":"Am J Hematol"},{"issue":"3","key":"8955_CR25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2007-07-100404","volume":"111","author":"I Vaknin","year":"2008","unstructured":"Vaknin I, et al. A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression. Blood. 2008;111(3):1437\u201347.","journal-title":"Blood"},{"issue":"12","key":"8955_CR26","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/sj.leu.2403985","volume":"19","author":"U Siegler","year":"2005","unstructured":"Siegler U, et al. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD\/SCID mice. Leukemia. 2005;19(12):2215\u201322.","journal-title":"Leukemia"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-017-8955-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T02:25:44Z","timestamp":1603074344000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-017-8955-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8955"],"URL":"https:\/\/doi.org\/10.1007\/s12026-017-8955-6","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"type":"print","value":"0257-277X"},{"type":"electronic","value":"1559-0755"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}